Trademark: 79279654
Word
RIBOMIC
Status Date
Tuesday, December 8, 2020
Registration Number
6213624
Registration Date
Tuesday, December 8, 2020
Filing Date
Tuesday, July 9, 2019
Published for Opposition
Tuesday, September 22, 2020
1 Chemicals for use in stabilization of RNA before purification and after purification under laboratory experiment and medical examination; chemical reagents for separating, detecting, measuring and analyzing proteins; ribonucleic acid (RNA) for laboratory use; nuclease for scientific or laboratory purposes; unsticking and separating preparations for scientific or laboratory purposes; chemicals for use in industry and science; artificial sweeteners; reagents for medical research
5 Reagents for medical purposes or medical reagents for diagnostic purposes; chemical preparations for pharmaceutical or medical purposes, namely, for treating vision failure, hearing failure, bone growth failure, lung failure, heart failure, articular failure, mental disorders, central nervous system disorder, blood disorders, skin disorders, pain, inflammation, kidney failure, liver failure, fibrosis, metabolic disorders, endocrine diseases, gynecological diseases, respiratory diseases, cardiovascular diseases, tissue regeneration and cancer; tissue-regenerative pharmaceutical preparations; pharmaceutical preparations for preventing and treating infectious diseases; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; reagent paper for medical purposes; gauze for dressings; capsules sold empty for pharmaceuticals; adhesive plasters for medical purposes; dental materials, namely, implants comprising living tissues; dietary supplements for humans
42 Testing, inspecting, analyzing, surveying, and research and development relating to pharmaceuticals; testing, inspecting or researching of medical technologies, and providing information and consultancy services relating thereto; research and development of pharmaceuticals and medical supplies; providing information relating to research of pharmaceuticals and medical supplies; testing, inspecting or researching of chemicals for medical use; quality evaluation and analysis of functions of chemical compositions available for medical purposes; providing information on medical researches; DNA analysis services for scientific research purposes; cytogenetic testing for scientific research purposes; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing temporary use of on-line non-downloadable computer programs for drug candidate discovery tools on data networks; designing of machines, apparatus, instruments including their parts or systems composed of such machines, apparatus and instruments; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research in the field of machines, apparatuses and instruments in the field of detection of trace components, hazardous substances and microorganisms
The color(s) blue and gray is/are claimed as a feature of the mark.
The mark consists of the wording "RIBOMIC" displayed on a partially blue background. The letters "RIB" and "MIC" are in blue and the letter "O" is in gray. The color white represents background or transparent areas and is not a part of the mark.
Apr 4, 2021
Final Decision Transaction Processed By Ib
Mar 11, 2021
Final Disposition Notice Sent To Ib
Mar 11, 2021
Final Disposition Processed
Mar 8, 2021
Final Disposition Notice Created, To Be Sent To Ib
Dec 8, 2020
Registered-Principal Register
Sep 22, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 22, 2020
Published For Opposition
Sep 18, 2020
Refusal Processed By Ib
Sep 2, 2020
Notification Of Notice Of Publication E-Mailed
Aug 20, 2020
Approved For Pub - Principal Register
Aug 20, 2020
Teas/Email Correspondence Entered
Aug 20, 2020
Correspondence Received In Law Office
Aug 20, 2020
Teas Response To Office Action Received
Aug 18, 2020
Notification Of Non-Final Action E-Mailed
Aug 18, 2020
Non-Final Action E-Mailed
Aug 18, 2020
Non-Final Action Written
Jul 27, 2020
Teas/Email Correspondence Entered
Jul 27, 2020
Correspondence Received In Law Office
Jul 27, 2020
Teas Response To Office Action Received
Apr 10, 2020
Refusal Processed By Ib
Mar 23, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Mar 23, 2020
Refusal Processed By Mpu
Mar 6, 2020
Application Filing Receipt Mailed
Mar 3, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Mar 2, 2020
Non-Final Action Written
Mar 2, 2020
Assigned To Examiner
Mar 2, 2020
New Application Office Supplied Data Entered In Tram
Feb 27, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
